Roz L - Search Results

1

Reduced FEZ1/LZTS1 expression and outcome prediction in lung cancer.

Nonaka D, Fabbri A, Roz L, Mariani L, Vecchione A, Moore GW, Tavecchio L, Croce CM, Sozzi G. Nonaka D, et al. Among authors: roz l. Cancer Res. 2005 Feb 15;65(4):1207-12. doi: 10.1158/0008-5472.CAN-04-3461. Cancer Res. 2005. PMID: 15735004 Free article.

2

Identification of PTEN-related sequences in glioma cells and in non-neoplastic cell lines.

Chiariello E, Roz L, Albarosa R, Magnani I, Finocchiaro G. Chiariello E, et al. Among authors: roz l. Cancer Lett. 1999 Apr 26;138(1-2):1-4. doi: 10.1016/s0304-3835(98)00357-7. Cancer Lett. 1999. PMID: 10378766

3

Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.

Sozzi G, Conte D, Mariani L, Lo Vullo S, Roz L, Lombardo C, Pierotti MA, Tavecchio L. Sozzi G, et al. Among authors: roz l. Cancer Res. 2001 Jun 15;61(12):4675-8. Cancer Res. 2001. PMID: 11406535

4

Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.

Roz L, Gramegna M, Ishii H, Croce CM, Sozzi G. Roz L, et al. Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3615-20. doi: 10.1073/pnas.062030799. Epub 2002 Mar 12. Proc Natl Acad Sci U S A. 2002. PMID: 11891319 Free PMC article.

5

Involvement of FHIT in lung carcinogenesis prospects for future clinical gene therapy applications.

Sozzi G, Andriani F, Gramegna M, Roz L. Sozzi G, et al. Among authors: roz l. Suppl Tumori. 2002 Jul-Aug;1(4):S62. Suppl Tumori. 2002. PMID: 12415825 Review. No abstract available.

6

Quantification of free circulating DNA as a diagnostic marker in lung cancer.

Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, Roz E, Cirenei N, Bellomi M, Pelosi G, Pierotti MA, Pastorino U. Sozzi G, et al. Among authors: roz l, roz e. J Clin Oncol. 2003 Nov 1;21(21):3902-8. doi: 10.1200/JCO.2003.02.006. Epub 2003 Sep 24. J Clin Oncol. 2003. PMID: 14507943

7

Detecting lung cancer in plasma with the use of multiple genetic markers.

Andriani F, Conte D, Mastrangelo T, Leon M, Ratcliffe C, Roz L, Pelosi G, Goldstraw P, Sozzi G, Pastorino U. Andriani F, et al. Among authors: roz l. Int J Cancer. 2004 Jan 1;108(1):91-6. doi: 10.1002/ijc.11510. Int J Cancer. 2004. PMID: 14618621

8

Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line.

Cavazzoni A, Petronini PG, Galetti M, Roz L, Andriani F, Carbognani P, Rusca M, Fumarola C, Alfieri R, Sozzi G. Cavazzoni A, et al. Among authors: roz l. Oncogene. 2004 Nov 4;23(52):8439-46. doi: 10.1038/sj.onc.1207847. Oncogene. 2004. PMID: 15361849

9

The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression.

Roz L, Andriani F, Ferreira CG, Giaccone G, Sozzi G. Roz L, et al. Oncogene. 2004 Dec 2;23(56):9102-10. doi: 10.1038/sj.onc.1208142. Oncogene. 2004. PMID: 15489891

10

Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.

Cirincione R, Lintas C, Conte D, Mariani L, Roz L, Vignola AM, Pastorino U, Sozzi G. Cirincione R, et al. Among authors: roz l. Int J Cancer. 2006 Mar 1;118(5):1248-53. doi: 10.1002/ijc.21473. Int J Cancer. 2006. PMID: 16152615

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters